insights_auto
Why is GANX down 5.22%?
Dive Deeperchevron_right
GANX:NASDAQ
Gain Therapeutics Inc
$0.99
arrow_downward
-5.22%(-0.054) 1D
Nov 16, 12:10:10 PM GMT-5 · USD
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for GANX...
Open
$1.01
High
$1.08
Low
$0.95
Mkt. cap
43.89M
Avg. vol.
527.99K
Volume
410.18K
52-wk high
$4.34
52-wk low
$0.94
EPS
-$0.43
Beta
0.29
Shares outstanding
44.52M
No. of employees
21
Open
$1.01
High
$1.08
Low
$0.95
Mkt. cap
43.89M
Avg. vol.
527.99K
Volume
410.18K
52-wk high
$4.34
52-wk low
$0.94
EPS
-$0.43
Beta
0.29
Shares outstanding
44.52M
No. of employees
21
News stories
From web sources and news partners
Benzinga
·
1 hour ago
Here’s How Much You Would Have Made Owning iShares S&P 500 Growth ETF Stock In The Last 15 Years
24/7 Wall St.
·
4 minutes ago
S&P 500 Drops 1.1% at Midday as Nasdaq Leads the Selloff
Trading News
·
8 minutes ago
Stock Market Today: S&P 500 SPX (7,562) 7,812 Target, Nasdaq, Dow, NVDA -3.7%
Traders Union
·
2 hours ago
Morgan Stanley lifts S&P 500 target to 8,700 for 2027
About Gain Therapeutics Inc
CEO-
Employees21
Founded2017
Headquarters-
SectorHealth Care
IndustryBiotechnology
Websitegaintherapeutics.com